Select your language/region

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes

16.1

SEK

-8.26

percent

Q-linea as an investment

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes

16.1

SEK

-8.26

percent

Future-proof Healthcare

CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.

 

 

Press releases

Press release

2026/07/10

Interim report January 1 – June 30 2026

Press release

2026/05/29

Annika Blondeau Henriksson new interim CFO

Press release

2026/05/27

BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
The annual general meeting of Q-linea AB (publ) (the “Company”), reg. no. 556729-0217, was held on 27 May 2026…
Read more >

Keep up to date – subscribe

Annika Blondeau Henriksson

Interim CFO

Mobile: +46 70 600 15 20

ir@qlinea.com

 

. . .
The share

Information about Q-linea stock price and trading volume